CLDI Archives - TinyGems

WednesdayMar 18, 2026 10:00 am

Scientists Discover Why Colon Cancer Diagnoses are Increasing in Young Adults

Researchers have found that people under 50 who develop colorectal cancer have unusually rigid colon tissue that helps tumors grow, offering the first clear explanation for rising cancer rates in younger adults. A University of Texas at Dallas team working with UT Southwestern Medical Center discovered that both tumor samples and surrounding healthy tissue were mechanically stiffer in younger patients than in older people with the same disease. Physical tissue properties appear to drive early-onset colorectal cancer, which has become the top cancer killer among Americans under 50. UT Dallas bioengineering Assistant Professor Jacopo Ferruzzi says this marks the first study showing how mechanical forces contribute to…

MondayMar 09, 2026 10:00 am

Ongoing Digital Monitoring Could Make Immunotherapy More Accessible

Ongoing digital monitoring could be about to solve one of modern medicine's most frustrating access problems. Life-extending cancer immunotherapies exist and there are numerous patients who could benefit from such therapies, but a mandatory hospital stay requirement currently makes access to immunotherapy nigh impossible for rural and underserved patients. However, a growing body of evidence now suggests that continuous remote monitoring could remove the need for hospital stays post immunotherapy. CAR-T cell therapies and related immunotherapies have reshaped what is possible for patients with certain blood cancers, producing remission rates that were unthinkable a generation ago. Thirteen of these treatments now carry FDA approval across two therapy categories. Getting them to patients,…

TuesdayFeb 17, 2026 10:00 am

Existing Cancer Drug Shows Potential in Reactivating Immunotherapy

An already approved cancer drug called Carfilzomib may help restore the effectiveness of CAR-T cell therapy in advanced multiple myeloma cases. Technical University of Munich researchers have discovered a molecular mechanism that causes cancer cells to evade treatment and have shown that blocking it can make immunotherapy work again in some patients. CAR-T cell therapy involves removing a patient's T cells, genetically altering them in the laboratory, and reintroducing them so they can recognize and attack cancer cells. For multiple myeloma, these engineered cells target a molecule known as BCMA, which appears on diseased plasma cells. The approach can extend survival, sometimes by years,…

TuesdayJan 20, 2026 10:00 am

Study Discovers Molecule of Gut Bacteria That Boosts Immunotherapy Response

Scientists have identified a compound produced by gut bacteria that sharply improves how tumors respond to immunotherapy, offering a potential breakthrough for patients who currently see little benefit from these treatments. The discovery centers on a small molecule called Bac429, which enhanced lung cancer treatment outcomes in mice and is now being developed into a drug suitable for human trials. The research was led by a team at the UF Health Cancer Institute and focuses on immune checkpoint inhibitors, a class of cancer drugs designed to help the immune system recognize and attack tumors. While these therapies have changed cancer care, their effectiveness remains limited. Rachel Newsome, study author…

WednesdayNov 05, 2025 10:00 am

Cancer Immunotherapy Could Be Transformed by Boosting Natural Killer Cells

Researchers at MIT and Harvard Medical School have developed a method to enhance natural killer cells that could transform cancer immunotherapy. The team engineered chimeric antigen receptor natural killer cells with modifications that prevent immune system rejection and improve their ability to destroy tumors. Early experiments in mice and laboratory human tissue show the enhanced cells are effective at fighting cancer and well tolerated, offering a promising foundation for next-generation treatments. Natural killer cells function as the body's first defense against virus-infected or cancerous tissue. They react immediately to suspect cells without requiring activation or priming. Chimeric antigen receptors engineered…

WednesdayOct 22, 2025 10:00 am

Study Suggests mRNA Covid Vaccine Could Boost Cancer Immunotherapy

New research published at the European Society for Medical Oncology conference on Sunday has revealed that the mRNA coronavirus vaccine could have an unintended benefit: boosting immunotherapy effectiveness. Although the research is still in its initial phases, experts say Covid vaccines may be able to improve immune function during immunotherapy and make the treatment more potent. Immunotherapy is a relatively new cancer treatment that uses a patient's immune system to fight tumor cells, avoiding the side effects typically associated with chemotherapy and radiation. The connection between coronavirus vaccines and improved immunotherapy efficacy will be explored further in a Phase 3…

WednesdayOct 08, 2025 10:00 am

Researchers Discover Why Cancer Immunotherapy Could Be Failing

A new study from Ohio State University Wexner Medical Center has discovered why immunotherapy fails in 60-80% of cancer patients. Researchers identified a previously unknown stress pathway called TexPSR that floods weakened immune cells with misfolded proteins, crippling their ability to attack tumors. Blocking this pathway in laboratory models restored immune cell function and significantly improved immunotherapy effectiveness across multiple cancer types. Immune system T cells recognize and fight infections and cancer, but often become weakened and lose effectiveness during prolonged battles with tumors. The Ohio State team found these depleted T cells collapse under misfolded proteins that trigger TexPSR,…

WednesdaySep 17, 2025 10:00 am

How Patients Can Boost Dietary Nutrient Intake During Cancer Treatment

Cancer treatment creates a cruel irony for patients: just when their bodies need more nutrients to fight the disease and recover from treatment, eating becomes one of the biggest challenges they face. Chemotherapy, radiation, and other cancer treatments can turn favorite foods into unpalatable options while simultaneously increasing the body's nutritional demands, putting cancer patients in a difficult position. Sarah Washburn, a dietitian with UCLA's cancer center, sees this struggle daily among her patients. Treatment side effects wreak havoc on taste buds, appetite, and digestion, making proper nutrition feel like an uphill battle when patients are already fighting for their…

WednesdayJul 16, 2025 10:00 am

Study Suggests Herpes Virus Can Be Modified to Fight Advanced Melanoma

Findings from a recent study suggest that the herpes virus can be modified into an effective treatment for some types of advanced melanoma. Conducted by researchers from the University of Southern California's Keck Medicine of USC, the clinical trial looked into the feasibility of deploying cancer-fighting herpes virus against advanced skin cancers. When researchers used a genetically engineered herpes simplex virus and combined it with immunotherapy, they found that the combination could reduce or completely destroy advanced melanoma tumors in 30% of the patients involved in the clinical trial. The clinical trial’s findings indicate that the herpes simplex virus, which…

MondayJun 02, 2025 10:00 am

Korean Researchers Develop AI to Predict Cancer Patients’ Response to Immunotherapy

A research team whose leadership is based in South Korea has developed an AI model for predicting how cancer patients will respond to immunotherapy. Designed to improve the precision of treatment in colorectal and gastric cancer, the AI model could provide physicians with a significantly more accurate tool for customizing therapies. Immunotherapy is a relatively new approach to cancer treatment that involves “training” the immune system to recognize and destroy malignant cells. In contrast to chemotherapy and radiation which can damage surrounding healthy tissue, immunotherapy allows physicians to more precisely target tumor cells. As a result, many patients undergoing immunotherapy…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

Tag: CLDI